PSIP1 and HIV-1 infection: ALLINIs, alternatively referred as lens-epithelium-derived growth-factor (LEDGF/p75)-integrase inhibitors (LEDGINs), noncatalytic site integrase inhibitors (NCINIs), IN-LEDGF/p75 allosteric inhibitors (INLAIs) and selective multimeric IN inhibitors (MINIs), are mechanistically distinct from active-site inhibitors INSTIs and therefore provide an important clinical complement to INSTIs in the clinical treatment of HIV-1 infection.12–18